Natalie is Head of Clinical Operations at Grey Wolf Therapeutics, where she provides program oversight for the timely, quality preparation and execution of the international clinical development program.
With over 20 years of management experience in both small biotechs and large pharmaceutical companies, she is an accomplished clinical leader within her field. She has a proven success record in operationalising Phase 1-3 clinical research studies with a focus in oncology, as well as the successful submission of CTAs, INDs, BLAs.
She has global experience running trials in many regions including EU, UK, Australia and US and brings a passion for innovative and patient focused research. Natalie has a B.Sc. (Hons) from Leeds University, UK.